The clearance of Inluriyo is another development among a group of oral medicines aiming to supplant a widely used, injectable ...

Lilly’s decision comes as the FDA has indicated potentially higher approval standards for drugs meant to preserve muscle in ...

Two months after its treatment for Duchenne-related cardiomyopathy was rejected, the company aligned with the agency on a ...

Decades of slow-moving research, along with broader failures of the healthcare system, have left millions of people in daily ...